High Body Mass Index and Severity of Coronavirus

High Body Mass Index and Severity of Coronavirus Disease 2019 (Covid-19): a Cohort Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04876898

Enrollment

114

Registered

2021-05-07

Start date

2020-07-01

Completion date

2021-02-28

Last updated

2021-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Pneumonia

Brief summary

A cohort study included 114 adult patients with confirmed COVID-19 were categorized by BMI levels on admission: overweight (25-29.9 kg/m2), and obesity (four categories: 30-34.9 kg/m2, 35-39.9 kg/m2, 40-44.9 kg/m2, and ≥45 kg/m2).

Interventions

OTHERprospective cohort in high body mass index patient with covid 19

A cohort study included 114 adult patients with confirmed COVID-19 were categorized by BMI levels

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Inclusion criteria

* patients older than 18 years * confirmed COVUID 19 infection * body mass index more than 25kg/m2

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
sever pneumonia	30 days	patients percentages
pneumonia	30 days	patients percentages
ICU admission	30 days	patients percentages

Secondary

Measure	Time frame	Description
length of hospital stay	30 days	days
clinical complication	30 days	patients percentages

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026